AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 23513246
Drug: Nasal high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high flow (NHF) oxygen therapy at 30 L/min
Trial: 23513246
Drug: Nasal high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high flow (NHF) oxygen therapy at 40 L/min
Trial: 23513246
Drug: Nasal high
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nasal high flow (NHF) oxygen therapy at 50 L/min
Trial: 21736780
Drug: Daily supplemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplemented with 600 μg retinol, 1·0 mg β‐carotene, 100 mg tocopherol, 300 mg ascorbic acid and 200 μg Se (Group A2)
Trial: 21736780
Drug: Daily supplemented
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily supplemented with antioxidants (Groups B2 and C2)
Trial: 19135997
Drug: Fluid administration
RxNorm normalized name: Fluid Administration Set
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluid administration greater than restriction limits
Trial: 14551140
Drug: 10 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg/kg IDEC‐131/E6040
Trial: 14551140
Drug: 5 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg/kg IDEC‐131/E6040
Trial: 14551140
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg IDEC‐131/E6040
Trial: 10609422
Drug: Interpersonal and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interpersonal and social rhythm therapy (IPSRT)
Trial: 9857856
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg imidapril
Trial: 8803516
Drug: 5 mg
RxNorm normalized name: talc 25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 mg imidapril
Trial: 8803516
Drug: 2.5 mg
RxNorm normalized name: biotin 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.5 mg imidapril
Trial: 9857856
Drug: All doses
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All doses of imidapril
Trial: 30592997
Drug: Nicotine (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine (2 mg)
Trial: 1419076
Drug: PGE2 infusion
RxNorm normalized name: PGE2
DrugBank: Dinoprostone (DB00917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: PGE2 infusion
Trial: 28206704
Drug: Alirocumab 75
RxNorm normalized name: alirocumab 75 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alirocumab 75 mg every 2 weeks (Q2W), increased to 150 mg Q2W at Week 12 if Week 8 LDL-C was ≥70 mg/dL
Trial: 26929777
Drug: Ezetimibe 10
RxNorm normalized name: ezetimibe 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ezetimibe 10 mg daily
Trial: 23150188
Drug: Ginkgo biloba
RxNorm normalized name: Ginkgo Biloba
DrugBank: Ginkgo biloba (DB01381)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ginkgo biloba (EGB 761) 60 mg twice daily
Trial: 17448130
Drug: Metformin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metformin + Intensive Lifestyle Intervention
Trial: 12243825
Drug: GM-CSF mouthwashes
RxNorm normalized name: axatilimab-csfr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GM-CSF mouthwashes (37.5 microg GM-CSF, 4 times daily)
Trial: 12243825
Drug: Sucralfate mouthwashes
RxNorm normalized name: Sucralfate
DrugBank: Sucralfate (DB00364)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sucralfate mouthwashes (1.0 g sucralfate, 4 times daily)
Trial: 9852907
Drug: Adenosine 15
RxNorm normalized name: ADENOSINE 15 g in 100 mL VAGINAL LIQUID [INNER SAVE Feminine Cleansing Mist]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adenosine 15 mumol/L
Trial: 21083590
Drug: Esomeprazole 40
RxNorm normalized name: esomeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 40 mg for 2 weeks
Trial: 20084725
Drug: Neoadjuvant chemotherapy
RxNorm normalized name: menthol
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neoadjuvant chemotherapy (cisplatin 80 mg/m2 on day 1 and Gemcitabine 1250 mg/m2 on days 1 and 8, every 3 weeks) followed by radiotherapy (60 Gy/30 fractions/6 weeks)
Trial: 9669077
Drug: Xylocaine (lidocaine)
RxNorm normalized name: Xylocaine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Xylocaine (lidocaine) spray
Trial: 9669077
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline spray
Trial: 12472516
Drug: No spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No spray
Trial: 7641121
Drug: Tenormin (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenormin (100 mg once daily)
Trial: 7641121
Drug: Tenolol (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenolol (100 mg once daily)
Trial: 30307122
Drug: 7-day STT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day STT (rabeprazole 20 mg twice daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily for 7 days)
Trial: 30307122
Drug: 7-day STT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7-day STT with bismuth (rabeprazole 20 mg twice daily, amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily, bismuth subcitrate 240 mg twice daily for 7 days)
Trial: 25604851
Drug: mDCF regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mDCF regimen (docetaxel 60 mg/m² on day 1, cisplatin 60 mg/m² on day 1, fluorouracil 600 mg/m²/day on days 1-5)
Trial: 25604851
Drug: CF regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CF regimen (cisplatin 75 mg/m² on day 1, fluorouracil 600 mg/m²/day on days 1-5)
Trial: 25348033
Drug: Hydroxychloroquine (HCQ)
DrugBank: Hydroxychloroquine (DB01611)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Hydroxychloroquine (HCQ) 200 to 400 mg per day
Trial: 30022544
Drug: MAL cream
RxNorm normalized name: PLO Transdermal Cream
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAL cream
Trial: 18459010
Drug: Alendronate (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alendronate (5 mg/day for the first 2 years and 10 mg/day thereafter)
Trial: 12473087
Drug: Physostigmine (cholinesterase
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physostigmine (cholinesterase inhibitor)
Trial: 1618254
Drug: No drug
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No drug (Control)
Trial: 25560423
Drug: Inhaled oxygen
RxNorm normalized name: oxygen Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled oxygen
Trial: 25082117
Drug: Olanzapine as
RxNorm normalized name: Olanzapine
DrugBank: Olanzapine (DB00334)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Olanzapine as an adjunct to lithium
Trial: 25082117
Drug: Chlorpromazine as
RxNorm normalized name: Chlorpromazine
DrugBank: Chlorpromazine (DB00477)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chlorpromazine as an adjunct to lithium
Trial: 17852792
Drug: Atorvastatin (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin (80 mg/day)
Trial: 14748765
Drug: HRT (oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HRT (oral 17beta‐estradiol 1 or 2 mg/day, plus cyclic dydrogesterone 10 mg)
Trial: 14748765
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of atorvastatin and HRT
Trial: 8256080
Drug: 200 mg
RxNorm normalized name: RNA 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg salbutamol
Trial: 8008027
Drug: Beta carotene
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta carotene (25 mg daily)
Trial: 8008027
Drug: Vitamins C
RxNorm normalized name: MULTIVITAMINS CAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamins C (1 g daily) and E (400 mg daily)
Trial: 31923632
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy with methylene blue and 660 nm diode laser (25 mW, dose: 19.23 J/CM2, probe diameter: 0.78 cm2) for three sessions (day 1, 3, 5)
Trial: 31923632
Drug: Sham laser
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham laser treatment on control side
Trial: 31537217
Drug: Intensive insulin
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intensive insulin therapy (IIT), keeping blood glucose at 4.4-7.8 mmol/L
Trial: 31537217
Drug: Conventional glycemic
RxNorm normalized name: Glycerin
DrugBank: Glycerin (DB09462)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional glycemic therapy (CGT), keeping blood glucose at 7.8-12.2 mmol/L
Trial: 26307899
Drug: Basal Bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basal Bolus insulin regimen (glargine once daily and glulisine before meals)
Trial: 24199923
Drug: Laparoscopy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopy combined with Leuprolide acetate (3.75 mg every 28 days)
Trial: 24199923
Drug: Laparoscopy combined
RxNorm normalized name: combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Laparoscopy combined with Goserelin acetate (3.6 mg every 28 days)
Trial: 16434174
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (FP) 1000 microg daily
Trial: 16434174
Drug: Inhaled fluticasone
RxNorm normalized name: fluticasone Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled fluticasone propionate (FP) 500 microg bid
Trial: 8933545
Drug: Cefaclor (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefaclor (40 mg/kg/day)
Trial: 8933545
Drug: Cefuroxime axetil
RxNorm normalized name: Cefuroxime Axetil
DrugBank: Cefuroxime (DB01112)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cefuroxime axetil (30 mg/kg/day)
Trial: 9215819
Drug: Paclitaxel 200
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 200 mg/m2 and Epirubicin 90 mg/m2
Trial: 9164208
Drug: Paclitaxel 225
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 225 mg/m2
Trial: 9215819
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 to 225 mg/m2
Trial: 9215819
Drug: Paclitaxel 175
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Paclitaxel 175 mg/m2 and 225 mg/m2
Trial: 9215819
Drug: Paclitaxel and
RxNorm normalized name: paclitaxel and encequidar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paclitaxel and Epirubicin combination
Trial: 17658985
Drug: Immediate Treatment
RxNorm normalized name: Aquaphor Immediate Relief Lip Balm
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate Treatment (IT)
Trial: 25678057
Drug: Conventional cardiac
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional cardiac resynchronization therapy (CONV)
Trial: 19291085
Drug: Four courses
RxNorm normalized name: Four-Way
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Four courses of treatment
Trial: 18349405
Drug: Mitoxantrone (12
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mitoxantrone (12 mg/m(2))
Trial: 8726152
Drug: Sedated with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sedated with chloral hydrate, inhaled aerosol of 7.7 microns mass median diameter (MMD)
Trial: 1444308
Drug: Magnesium oxide
RxNorm normalized name: Magnesium Oxide
DrugBank: Magnesium oxide (DB01377)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Magnesium oxide (500 mg) with DR-3355 (100 mg)
Trial: 1444308
Drug: Ferrous sulfate
RxNorm normalized name: Ferrous Sulfate
DrugBank: Ferrous fumarate (DB14491)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ferrous sulfate (160 mg) with DR-3355 (100 mg)
Trial: 1444308
Drug: Calcium carbonate
RxNorm normalized name: Calcium Carbonate
DrugBank: Calcium carbonate (DB06724)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Calcium carbonate (1 g) with DR-3355 (100 mg)
Trial: 1444308
Drug: Ranitidine (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ranitidine (150 mg) with DR-3355 (100 mg)
Trial: 1444308
Drug: DR-3355 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DR-3355 (100 mg) alone
Trial: 24576321
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (200 mW) at 2 J
Trial: 24576321
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (200 mW) at 6 J
Trial: 24576321
Drug: Low-level laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-level laser therapy (200 mW) at 10 J
Trial: 17655657
Drug: Finasteride 5
RxNorm normalized name: finasteride 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Finasteride 5 mg without counseling on sexual side effects (group 1)
Trial: 10051060
Drug: Sodium valproate
RxNorm normalized name: sodium valproate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sodium valproate (VPA) 2000 mg
Trial: 25692980
Drug: Yacon-based product
RxNorm normalized name: 4XLA Base Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yacon-based product (YBP) with 10 g fructooligosaccharide (FOS)/inulin per day in orange juice
Trial: 25692980
Drug: Maltodextrin in
RxNorm normalized name: Maltodextrin
DrugBank: Maltodextrin (DB12583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maltodextrin in orange juice (control) with 25 g per day
Trial: 23065117
Drug: Melodic Based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Melodic Based Communication Therapy (MBCT)
Trial: 23065117
Drug: Traditional Speech
RxNorm normalized name: sodium fluoride
DrugBank: Sodium fluoride (DB09325)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Traditional Speech and Language Therapy
Trial: 9540243
Drug: Treatment-based program
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment-based program
Trial: 7986972
Drug: Paroxetine 30
RxNorm normalized name: PARoxetine 30 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paroxetine 30 mg daily for two days
Trial: 20886654
Drug: Maitland Grade
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maitland Grade III anterior‐to‐posterior joint mobilization treatment
Trial: 19034470
Drug: Antibiotic prophylaxis
RxNorm normalized name: STONE PROPHYLAXIS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic prophylaxis after umbilical cord clamping (Group B)
Trial: 2655184
Drug: PY108-068 (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PY108-068 (150 mg/day in divided doses)
Trial: 1026543
Drug: Amylobarbitone sodium
RxNorm normalized name: Amylobarbitone sodium
DrugBank: Amobarbital (DB01351)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amylobarbitone sodium 200 mg
Trial: 20549633
Drug: BDE mixture
RxNorm normalized name: brown mixture
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BDE mixture DE‐71 at doses of 0.5, 5, and 25 mg kg(‐1) body weight/day for 21 weeks
Trial: 17241416
Drug: Botulinum toxin
RxNorm normalized name: Botulinum toxin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Botulinum toxin type B (BTX-B) at doses ranging from 250 to 3,000 U
Trial: 2898363
Drug: Nifedipine 30
RxNorm normalized name: nifedipine 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nifedipine 30 mg day-1
Trial: 25661136
Drug: Oral diazepam
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral diazepam
Trial: 9744143
Drug: Felodipine 5-10
RxNorm normalized name: felodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine 5-10 mg once daily
Trial: 23132262
Drug: General anesthesia
RxNorm normalized name: Ethers for general anesthesia
FDA approved: no
EMA approved: no
PMDA approved: no
Description: General anesthesia alone (Group G)
Trial: 24102416
Drug: Furosemide (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Furosemide (20 mg orally each day)
Trial: 24102416
Drug: Amlodipine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine (5 mg orally each day)
Trial: 8893678
Drug: 1.25 mg
RxNorm normalized name: menthol 1.25 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.25 mg of estrone sulfate (E1S)
Trial: 8893678
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg of 17 alpha-dihydroequilin sulfate
Trial: 8893678
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of E1S and 17 alpha-dihydroequilin sulfate
Trial: 11975938
Drug: HMB/Arg/Gln (beta-hydroxy-beta-methylbutyrate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HMB/Arg/Gln (beta-hydroxy-beta-methylbutyrate 3 g/d, L-arginine 14 g/d, L-glutamine 14 g/d)
Trial: 8712393
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 0.2% isoflurane and 30% nitrous oxide in oxygen
Trial: 8712393
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of 0.4% isoflurane and 30% nitrous oxide in oxygen
Trial: 2066595
Drug: HR 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HR 0.5 g group (0.5 g X 2/day of CPR)
Trial: 2066595
Drug: HR 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HR 1.0 g group (1.0 g X 2/day of CPR)
Trial: 6843050
Drug: Aminophylline (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline (6 mg/kg body weight, i.v.)
Trial: 22067410
Drug: Sildenafil (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sildenafil (50 mg three times a day)
Trial: 17584826
Drug: Weekly docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Weekly docetaxel administration
Trial: 17584826
Drug: Cumulative docetaxel
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Cumulative docetaxel doses and number of chemotherapy cycles
Trial: 12207094
Drug: Low-salt diet
RxNorm normalized name: Low-energy diets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-salt diet (2 g NaCl/day)
Trial: 12207094
Drug: High-salt diet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-salt diet (20-23 g)
Trial: 12207094
Drug: Low-salt diet
RxNorm normalized name: Low-energy diets
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-salt diet (2 g NaCl/day) after high-salt diet
Trial: 12207094
Drug: Duration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Duration of dialysis treatment
Trial: 29524664
Drug: Cavity shave
RxNorm normalized name: Shave Grass Top
DrugBank: Equisetum arvense top (DB14349)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cavity shave margins excision or re-excision of positive margins; specific details on dosage and duration not available.
Trial: 29524664
Drug: High-grade ductal
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-grade ductal carcinoma in situ; specific details on dosage and duration not available.
Trial: 21564271
Drug: ST(1), no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ST(1), no treatment applied (control)
Trial: 2700321
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg ketanserin dissolved in the mouth
Trial: 4213977
Drug: Empiric treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Empiric treatment with carbenicillin and gentamicin
Trial: 30955978
Drug: Tdap vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tdap vaccine (case group)
Trial: 23187956
Drug: Soybean protein
RxNorm normalized name: Soybean protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soybean protein supplement (40g, 89.3 mg isoflavones)
Trial: 23187956
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein supplement (40g)
Trial: 10778915
Drug: Inhaled corticosteroids
RxNorm normalized name: CORTICOSTEROIDS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled corticosteroids (IHC) for 8 weeks
Trial: 10778915
Drug: Long-term treatment
RxNorm normalized name: benzethonium
DrugBank: Benzethonium (DB11125)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Long-term treatment with IHC
Trial: 10778915
Drug: Sputum from
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sputum from COPD patients before treatment with NAC
Trial: 8406147
Drug: Bismuth subsalicylate
RxNorm normalized name: Bismuth Subsalicylate
DrugBank: Bismuth subsalicylate (DB01294)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Bismuth subsalicylate (600 mg three times daily), metronidazole (400 mg three times daily), tetracycline (500 mg three times daily), and ranitidine (300 mg in the evening) for two weeks
Trial: 22344742
Drug: Clonazepam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (0.5 mg/day, n = 10)
Trial: 22344742
Drug: Clonazepam (0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonazepam (0.5 mg/day)
Trial: 20210263
Drug: Generic medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic medications
Trial: 7589632
Drug: Goserelin acetate
RxNorm normalized name: Goserelin Acetate
DrugBank: Goserelin (DB00014)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Goserelin acetate (3.6 mg SC depot formulation once monthly for 6 months)